CAPTRUST Financial Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.1M | Buy |
95,054
+1,777
| +2% | +$349K | 0.03% | 395 |
|
|
2026
Q1 | $18.3M | Buy |
93,277
+67,960
| +268% | +$13.2M | 0.03% | 387 |
|
|
2025
Q4 | $4.39M | Buy |
25,317
+8,136
| +47% | +$1.48M | 0.01% | 712 |
|
|
2025
Q3 | $3.27M | Sell |
17,181
-118
| -0.7% | -$20.9K | 0.01% | 803 |
|
|
2025
Q2 | $3.11M | Sell |
17,299
-158
| -0.9% | -$27.4K | 0.01% | 785 |
|
|
2025
Q1 | $2.95M | Buy |
17,457
+3,005
| +21% | +$494K | 0.01% | 750 |
|
|
2024
Q4 | $2.18M | Buy |
14,452
+567
| +4% | +$88.2K | 0.01% | 851 |
|
|
2024
Q3 | $2.16M | Sell |
13,885
-165
| -1% | -$24.6K | 0.01% | 834 |
|
|
2024
Q2 | $1.92M | Sell |
14,050
-211
| -1% | -$28.9K | 0.01% | 840 |
|
|
2024
Q1 | $1.9M | Sell |
14,261
-4,916
| -26% | -$638K | 0.01% | 826 |
|
|
2023
Q4 | $2.64M | Buy |
19,177
+344
| +2% | +$45.2K | 0.01% | 794 |
|
|
2023
Q3 | $2.29M | Sell |
18,833
-25,261
| -57% | -$3.37M | 0.01% | 811 |
|
|
2023
Q2 | $6.2M | Buy |
44,094
+2,671
| +6% | +$368K | 0.02% | 440 |
|
|
2023
Q1 | $5.86M | Buy |
41,423
+742
| +2% | +$106K | 0.03% | 417 |
|
|
2022
Q4 | $6.36M | Buy |
40,681
+1,054
| +3% | +$151K | 0.03% | 384 |
|
|
2022
Q3 | $4.86M | Sell |
39,627
-194
| -0.5% | -$25.5K | 0.03% | 405 |
|
|
2022
Q2 | $5.29M | Buy |
39,821
+3,131
| +9% | +$427K | 0.03% | 363 |
|
|
2022
Q1 | $5.02M | Sell |
36,690
-3,212
| -8% | -$448K | 0.03% | 368 |
|
|
2021
Q4 | $6.9M | Sell |
39,902
-2,625
| -6% | -$399K | 0.05% | 297 |
|
|
2021
Q3 | $6.18M | Buy |
42,527
+6,371
| +18% | +$932K | 0.05% | 284 |
|
|
2021
Q2 | $4.77M | Sell |
36,156
-2,546
| -7% | -$333K | 0.04% | 307 |
|
|
2021
Q1 | $4.97M | Sell |
38,702
-99
| -0.3% | -$12.2K | 0.05% | 271 |
|
|
2020
Q4 | $4.62M | Buy |
38,801
+23,575
| +155% | +$2.87M | 0.06% | 258 |
|
|
2020
Q3 | $1.72M | Sell |
15,226
-2,681
| -15% | -$317K | 0.03% | 372 |
|
|
2020
Q2 | $2.04M | Sell |
17,907
-1,343
| -7% | -$142K | 0.03% | 342 |
|
|
2020
Q1 | $1.52M | Buy |
19,250
+191
| +1% | +$19.8K | 0.03% | 346 |
|
|
2019
Q4 | $2.02M | Buy |
19,059
+18,511
| +3,378% | +$1.93M | 0.03% | 372 |
|
|
2019
Q3 | $59K | Sell |
548
-1,604
| -75% | -$165K | ﹤0.01% | 938 |
|
|
2019
Q2 | $219K | Buy |
2,152
+156
| +8% | +$15K | 0.01% | 540 |
|
|
2019
Q1 | $179K | Buy |
1,996
+188
| +10% | +$16.3K | 0.01% | 544 |
|
|
2018
Q4 | $151K | Sell |
1,808
-837
| -32% | -$78.5K | 0.01% | 486 |
|
|
2018
Q3 | $285K | Sell |
2,645
-67
| -2% | -$7.35K | 0.01% | 375 |
|
|
2018
Q2 | $298K | Buy |
2,712
+1,479
| +120% | +$154K | 0.02% | 299 |
|
|
2018
Q1 | $121K | Sell |
1,233
-482
| -28% | -$49.4K | 0.01% | 409 |
|
|
2017
Q4 | $169K | Buy |
+1,715
| New | +$163K | 0.01% | 349 |
|
Other funds holding DGX
EIG
CAPTRUST Financial Advisors's DGX Position: Q2 2026 in Review
CAPTRUST Financial Advisors increased its Quest Diagnostics (DGX) stake by 1.9% in Q2 2026, buying an estimated $349K and bringing the position to 95,054 shares worth $20.1M. The position accounts for 0.03% of the portfolio, ranked #395.
CAPTRUST Financial Advisors first reported a position in DGX in Q4 2017 and has held it in 35 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- CAPTRUST Financial Advisors held 95,054 shares of Quest Diagnostics worth $20.1M as of Q2 2026.
- CAPTRUST Financial Advisors bought 1,777 Quest Diagnostics shares in Q2 2026, an estimated $349K.
- Quest Diagnostics made up 0.03% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #395 holding.
- CAPTRUST Financial Advisors first reported a position in Quest Diagnostics in Q4 2017 and has held it in 35 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.